Key Points
Torrent Pharma said today there is no information requiring disclosure under listing regulations, after reports that the pharmaceutical company held talks to buy a stake in bigger rival Cipla...
"The Company has noted that the news item refers to a potential sale of shares by its promoters pertaining. to their involvement in the acquisition of Ciplas shares..
The Economic Times today reported citing several people with knowledge of the matter that Torrent Pharma is cranking up its efforts to put together financing to buy out the promoter family of Cipla..
This includes a likely Rs 8,300 crore ($1 billion) equity infusion from one or more private equity players, they said.. Ahmedabad-based Torrent has reached out to several PE funds, including Advent International, Bain Capital, Warburg Pincus and CVC Capital, for a minority stake in a consortium, ET reported today...
Torrent Pharma today said if and when any proposal warranting a disclosure is considered by the board of directors of the company, it shall promptly comply with the disclosure obligations..
You might be interested in
Torrent Pharma joins race to acquire stake of Cipla promoters: Report
23, Aug, 23A successful deal will take Torrent Pharma to the second-largest company by revenues in India. In domestic formulation business, it will overtake market leader Sun Pharma.